// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Septic arthritis of the pubic symphysis: a rare cause of hip and pubic pain

Alexis Jones - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infectious arthritis

Ciprofloxacin

A single centre experience of anti-HMGCR and anti-SRP necrotising myopathies: a retrospective cohort study

Rhys Thomas - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Necrotizing myopathy

N/A

Adverse infusion reactions to rituximab in myositis: a retrospective analysis

Sara I X Pires - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Myositis

Rituximab

A novel, theory based intervention to promote engagement in physical activity in early rheumatoid arthritis: quantitative findings

Rachel Thomas - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Osteoarthritis is associated with increased contact with secondary care in both sexes

Michael A Clynes - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The use of YouTube for the self-management of arthritis and joint pain: a patient and public involvement study

Osman Ahmed - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Comparison of the functional impact of verum and placebo thumb base orthoses: a proof of concept study

Marcus S T Loyley - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neglected bodily senses in women living with vertebral fractures: a focus group study

Sarah Drew - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastric antral vascular ectasia

N/A

Prevalence of musculoskeletal pain and its effects among secondary teachers in the district of Colombo in Sri Lanka

Enoka P Wickramasinghe - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of a nurse-led integrated care review based in primary care to identify and improve the management of co-morbidities in patients with inflammatory rheumatological conditions: the INCLUDE study

Annabelle R Machin - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of steroids on fracture risk and BMD in rheumatoid arthritis patients: an observational study

Aditi Ranjan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Retrospective cohort study of early real-life experience with baricitinib in rheumatoid arthritis

Jeanette Tan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study

May Nwe Lwin - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

Assessing outcome data in early arthritis with a focus on fatigue

Claire R Wood - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The relationship between lipid profile changes and inflammation across the Phase 3 sarilumab rheumatoid arthritis (RA) development programme

Christina Charles-Schoeman - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Patients with arthritis starting on the biosimilar drug, Benepali, de novo: a single-centre retrospective observational study

Anastasia- Vasiliki Madenidou - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Etanercept biosimilar

Emotional health and well-being matters

Matthew Bezzant - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Qualitative study of public perceptions of predictive genetic testing for rheumatoid arthritis

Imogen Wells - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rheumatoid arthritis

N/A

The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: a systematic literature review

Elizabeth Smith - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Lack of association between nailfold capillary microscopic changes and cardiovascular risk in systemic sclerosis patients

Stergios Soulaidopoulos - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Copyright © 2026. QuantiNova All rights reserved